Hematology, Oncology, Bone Marrow Transplant, And Cellular Therapy Publications
The listings below highlight research and contributions by UW Pediatrics faculty. These listings are not intended as a citation but rather a call-out of UW Pediatrics contributions. For official authorship please click the publication link provided.
July 2024
- Perspectives of pediatric oncologists on referral for CAR-T therapy: a mixed methods pilot study (PMID: 39078720 ). JNCI Cancer Spectrum.
UW Peds contributing authors: Anurekha G Hall, Devan M Duenas, Adam J Lamble, Elizabeth Gruber, Benjamin Wilfond Bioethics and Palliative Care Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy
March 2024
- Germline genetic testing and survival outcomes among children with rhabdomyosarcoma (PMID: 38546643). JAMA Network Open.
UW Peds contributing authors: Douglas Hawkins Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy
January 2024
- Inequitable Poverty Exposures: A Subspecialty Opportunity to Address Disparities. Hospital Pediatrics.
UW Peds contributing authors: Kristine Karvonen Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy
December 2023
- Financial hardship among siblings of long-term survivors of childhood cancer: A Childhood Cancer Survivor Study report (PMID: 38100563). Cancer.
UW Peds contributing authors: Tim Ohlsen, Arti Desai, Eric Chow Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy - Primary Care Utilization and Cardiovascular Screening in Adult Survivors of Childhood Cancer (PMID: 38091040). JAMA Network Open.
UW Peds contributing authors: Tim Ohlsen, Eric Chow Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy
November 2023
- Recent advances in the treatment of childhood cancers (PMID: 37966889). Current Opinion in Pediatrics.
UW Peds contributing authors: Timothy Ohlsen, Melissa Martos, Douglas Hawkins Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy
September 2023
- Altered peripheral blood gene expression in childhood cancer survivors with anthracycline-induced cardiomyopathy: a COG ALTE03N1 report (PMID: 37750583). Journal of the American Heart Association.
UW Peds contributing authors: Douglas Hawkins Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy
August 2023
- Individualized antibiotic plans as a quality improvement initiative to reduce carbapenem use for hematopoietic cell transplant patients at a freestanding pediatric hospital (PMID: 37647637). Clinical Infectious Diseases.
UW Peds contributing authors: Matthew Kronman, Jennifer Wilkes, Paul Carpenter, Janet Englund, Scott Weissman Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy Infectious Disease - The Childhood Cancer Data Initiative: using the power of date to learn from every child and young adult with pediatric cancers (PMID: 37267580). Journal of Clinical Oncology.
UW Peds contributing authors: Douglas Hawkins Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy - Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy. Scientific Reports.
UW Peds contributing authors: Douglas Hawkins Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy
July 2023
- Outcomes following preoperative chemoradiation +/- pazopanib in non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): a report from Children's Oncology Group (COG) and NRG Oncology (PMID: 37523624). Journal of Clinical Oncology.
UW Peds contributing authors: Douglas Hawkins Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy - Rare tumors: opportunities and challenges from the Children's Oncology Group perspective. European Journal of Cancer Paediatric Oncology .
UW Peds contributing authors: Douglas Hawkins Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy - Children’s Oncology Group’s 2023 blueprint for research (PMID: 37433635). Pediatric Blood and Cancer.
UW Peds contributing authors: Douglas Hawkins Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy - Combination early phase trials of anticancer agents in children and adolescents (PMID: 37015036). Journal of Clinical Oncology.
UW Peds contributing authors: Douglas Hawkins Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy
June 2023
- Paediatric strategy forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administr (PMID: 37441939). European Journal of Cancer .
UW Peds contributing authors: Douglas Hawkins Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy - A pilot study evaluating the use of sirolimus in children and young adults with desmoid-type fibromatosis (PMID: 37283290). Pediatric Blood and Cancer.
UW Peds contributing authors: Douglas Hawkins Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy - Haptoglobin gene expression and anthracycline-related cardiomyopathy in childhood cancer survivors: a Children’s Oncology Group COG-ALTE03N1 report (PMID: 37397079). JACC CardioOncol.
UW Peds contributing authors: Douglas Hawkins Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy - Germline genetic variants and pediatric rhabdomyosarcoma outcomes: a report from the Children’s Oncology Group (PMID: 36951526). Journal of the National Cancer Institute .
UW Peds contributing authors: Douglas Hawkins Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy
May 2023
- Tazemetostat for tumors harboring SMARCB1, SMARCA4 or EZH2 alterations: results from NCI-COG Pediatric MATCH (PMID: 37228094). Journal of the National Cancer Institute.
UW Peds contributing authors: Douglas Hawkins Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy - TP53 germline pathogenic variant frequency in anaplastic rhabdomyosarcoma: a Children’s Oncology Group report (PMID: 37194615). Pediatric Blood and Cancer.
UW Peds contributing authors: Douglas Hawkins Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy - Circulating tumor DNA is prognostic in intermediate risk rhabdomyosarcoma: a report from the Children’s Oncology Group (PMID: 36724417). Journal of Clinical Oncology.
UW Peds contributing authors: Douglas Hawkins Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy
April 2023
- Thrombophilia screening in the routine clinical care of children with arterial ischemic stroke (PMID: 37114761). Pediatric Blood & Cancer.
UW Peds contributing authors: Kristin Maher, Helén Dichek, Catherine Amlie-Lefond Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy - Neoadjuvant pazopanib in non-rhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children’s Oncology Group and NRG Oncology (PMID: 36779385). Journal of Surgical Oncology .
UW Peds contributing authors: Douglas Hawkins Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy - National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH) (PMID: 36662819). Clinical Cancer Research.
UW Peds contributing authors: Douglas Hawkins Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy
March 2023
- Genomewide association study identifies ROBO2 as a novel susceptibility gene for anthracycline-related cardiomyopathy in childhood cancer survivors: A report from the Childhood Cancer Survivor Study and the COG-ALTE03N1 Study (PMID: 36508697). Journal of Clinical Oncology.
UW Peds contributing authors: Douglas Hawkins Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy